Processa Pharmaceuticals, Inc.
PCSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533743
In the last 90 days, Processa Pharmaceuticals, Inc. insiders filed 5 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $498.3K in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Processa Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 18 | 18 | 0 |
| Shares | 1.07M | 1.13M | +62.0K (+5.8%) |
| Value | $3.22M | $3.24M | +$18.0K (+0.6%) |
New holders (3)
Institutions that held Processa Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 11,600 | $33.0K | 0.00% |
| Vectors Research Management, LLC | 4,000 | $11.0K | 0.00% |
| Essex Investment Management Co LLC | 2,300 | $6.00K | 0.00% |
Sold out (3)
Institutions that held Processa Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Solas Capital Management, LLC | 22,844 | $69.0K |
| UBS Group AG | 1,115 | $3.00K |
| Whittier Trust Co | 22 | $0 |